Summary:
A Phase 3 Randomized, Double-Blind, Placebo-controlled study to evaluate the efficacy and safety of study medication in Participants with Gout
Qualified Participants Must:
• Between the ages of 18 and 85
•
Have had 2 or more self reported gout flare ups in the last 12 months
Qualified Participants May Receive:
Compensation for time and/or travel, meet with a Physician